Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Acalabrutinib (100 mg twice per day) assessed for thrombus formation at injured arterioles of the mice
SR-717 demonstrates broad interspecies and interallelic specificity
25 Suppl 1:250-1
25 μg) into the amygdala or dorsal hippocampus 10 min prior to a retention test partially blocks the expression of stepdown inhibitory avoidance in rats 24 h after training
Zucker rats
Silodosin - CAS# 160970-54-7 binol Acalabrutinib (100 mg twice perSilodosin, also known as KMD 3213, is an 1 adrenoceptor antagonist approved for the symptomatic treatment of benign prostatic hyperplasia. It acts as an 1 adrenoceptor antagonist with high uroselectivity (selectivity for the prostate). Since silodosin has high affinity for the 1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other 1 blockers). Product information CAS Number: 160970 54 7 Molecular Weight: 495. 53
US$ 15.26
US$ 19.95
US$ 29.95
US$ 24.95
US$ 465.70